Ryan & Maniskas, LLP Announces Investigation of ZOLL Medical Corporation
13 Março 2012 - 11:42AM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/zoll) is
investigating potential claims against the board of directors of
ZOLL Medical Corporation (“ZOLL Medical” or the "Company") (NASDAQ:
ZOLL) concerning possible breaches of fiduciary duty and other
violations of law related to the Company’s efforts to sell ZOLL
Medical to Asahi Kasei Corporation in a transaction valued at
approximately $2.2 billion.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to the approval of the
transaction by Company’s board of directors; in particular, whether
the Company undertook a fair process to obtain fair consideration
for all shareholders of ZOLL Medical. For more information
regarding our investigation, please contact Ryan & Maniskas,
LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or
by email at rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/zoll.
Under the terms of the agreement, ZOLL Medical shareholders will
receive $93 for each share of ZOLL Medical stock they own.
If you own shares of ZOLL Medical and would like to learn more
about these claims or if you wish to discuss these matters and have
any questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign
up online, visit: www.rmclasslaw.com/cases/zoll. You may also email
Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information
about class action cases in general, please visit our website:
www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide.
Zoll (NASDAQ:ZOLL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Zoll (NASDAQ:ZOLL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Zoll Medical Corp. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Ryan & Maniskas, LLP